[Fis] [BULK] Re: [BULK] Re: Fis Digest, Vol 99, Issue 16

Karl Javorszky karl.javorszky at gmail.com
Fri Mar 10 15:32:30 CET 2023 

Oh Krassimir, (and Pedro et al),

This is exactly what makes fis such a valuable asset. No need for
grandstanding, centered on the subject matter, with freedom in style but
attention to polite forms.

Life does find the small habitat to carry on. Scientific enquiry, collegial
curiosity and the need to exchange views on concepts not established yet is
finding for themselves a forum for exchange.

We can thank each other.

Karl




Krassimir Markov <itheaiss en gmail.com> schrieb am Fr., 10. März 2023, 15:13:

> Dear Plamen,
>
> We in Bulgaria have a saying that applies to the case you are commenting
> on.
> "He who eats the cabbage pie is not crazy, but the one who gives it to
> him!"
>
> Let's not confuse the ChatGPT ad campaign with the upcoming paid usage.
> Obviously, many different examples will appear now, how useful it is, but
> soon everything will calm down, as happened with Google.
> Today, no one worries that researchers mostly use search engines to find
> the articles they need.
>
> ChatGPT has one very serious drawback, which, as we say in Bulgaria, is
> "the pebble that turns the car". This is because *ChatGPT does not
> specify the sources from which it uses data*.
>
> Consequently, reviewers will soon start suspending articles citing ChatGPT
> as a source. It's only a matter of time before that happens. Just like the
> Wikipedia citation gone wrong! Let me remember that ChatGPT uses Wikipedia
> as one of the main sources.
>
> But it won't be that easy. As I pointed out in my letter during your
> discussion of the roots of modern civilization, a major root of its
> development is the emergence of *the knowledge market*. It is the market
> of knowledge today that is the main driver of the growth of the "gray
> stream" in science.
>
> Every publisher has a strong interest in selling their production. I am
> also a publisher and have over 30 years of extensive experience in this
> field. The price of over 1,000 euros to publish an open access article is
> now common.
> The difference with earlier times when articles were published for free is
> that back then you had to pay to read them. After this opportunity was
> exhausted (there are millions of articles that have not been read even
> once!), publishers began to take the money up front from the authors!
>
> You want to advertise your scientific results - pay a lot to advertise
> them!
>
> As I am also a publisher of scientific journals and books, this is
> precisely the approach I have taken since the beginning of my activity 30
> years ago. ITHEA's products have always been and will always be freely
> available, and their publication has been done either at the expense of
> sponsorship or at the expense of the authors themselves, who pay a
> so-called "publication fee" for the publication. 20 years after ITHEA, the
> world has spoken and moved to this style.
>
> In conclusion, I would like to point out that technical means are not a
> problem, but their smart use!
>
> With best wishes,
> Krassimir
>
>
>
>
>
> На пт, 10.03.2023 г. в 12:37 ч. <fis-request en listas.unizar.es> написа:
>
>> Send Fis mailing list submissions to
>>         fis en listas.unizar.es
>>
>> To subscribe or unsubscribe via the World Wide Web, visit
>>         http://listas.unizar.es/cgi-bin/mailman/listinfo/fis
>> or, via email, send a message with subject or body 'help' to
>>         fis-request en listas.unizar.es
>>
>> You can reach the person managing the list at
>>         fis-owner en listas.unizar.es
>>
>> When replying, please edit your Subject line so it is more specific
>> than "Re: Contents of Fis digest..."
>> Today's Topics:
>>
>>    1. Fwd: ChatGPT in medical publishing (Dr. Plamen L. Simeonov)
>>
>>
>>
>> ---------- Forwarded message ----------
>> From: "Dr. Plamen L. Simeonov" <plamen.l.simeonov en gmail.com>
>> To: fis <fis en listas.unizar.es>, Covid-19 Therapy <
>> covid-19-therapy en googlegroups.com>
>> Cc:
>> Bcc:
>> Date: Fri, 10 Mar 2023 11:35:55 +0100
>> Subject: [Fis] Fwd: ChatGPT in medical publishing
>>
>> My personal opinion: ChatGPT and other AI ghostwriting tools are going to
>> be the end of "evidence-based medicine" . I only hope they will not become
>> the beginning of a "deja-vu nightmare medicine". The more a phrase is
>> repeated and circulated, the more it (the phrase) and not the real event
>> becomes reality/evidence. And chatbots can do this endlessly.  Hallelujah!
>> Maybe one day judgebots will prosecute us for something we don't have the
>> slightest idea of. Aldous Huxley and George Orwell welcome the almighty AI
>> Wizard of Oz.I do hope I am totally wrong.
>>
>> Best,
>>
>> Plamen
>> Cureus Newsletter - March 2023
>> JOURNAL OF MEDICAL SCIENCE NEWSLETTER | MARCH 2023
>>
>> <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B95w2rSzNng98V8sUPr-2FtrXHAsA0L-2BaZYRW3m8oiAYAGFqigN-2FLremuTKQqlPFRzyn4WHss1o66XTyoBY7zCK1kMIMPZQCR-2BV66XjAXmRjRww8cNzmJ6Hl3vJoSi7q8VdmB2Rz52wDi7wvReL8gyMlINShNC06Q2hx8I601j6QgBg1riQS_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2Bz6FCq8YOMyw3B2TT5iOCaJl4MYiZp-2BO-2BrWtzBeI-2FBop-2FlhOKAXk8bgMTI1uX7D3StLGBcPb15pNO4iBjB7VA4HclH-2FDLtnyJd8kKkCdu4lBpw8DefEt0vM7v5axPIW0k-2Bsa3KYesYrBRSSAFqsv6ytcYd2j9fdTBodJZVx9p9rQqO1k-2F7nlRp0wR1aQs6yCAqLZ8FcN83QqCgDmocCUPLcQ-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IKKSGFGU$>
>> <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B95w2rSzNng98V8sUPr-2FtrXHDTTNzq7NHI8xDIsSl9hYIq0T7DL0FO6kEL7RZAPPbcirJFkmd20Y4YqUewjmTnYeJoTeihGXvuBO09U9kFQJFoVwLEEdq7TFBccKfglxfHc2HAodCJPTipyWRlth3aZhxrGkhkBfNWZrJbNzzNmpvgUeB0_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2BzjIQQztY6gI3vdQ5wnsBT-2Bu1bpzDsaqNRaeatNjySCyFO6PwP8suxbUvQxJ91JTyBoFxPMdt1RZNDsdBiviHHsfEB8-2BqyBdaHtNIvSCh5pqIBRJBytqoLyrYONY89k8dtmeNqtU6ssRglKbxLnqre7eoe-2B9viuV9worKrZmqMJzipAUO3jpBbvRi56NCzPCnDnOjOdHXz33uLPyH4V-2BKp-2FA-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IB58b8I1$>
>>
>> Hi ,
>>
>> Every decision made by the Cureus staff and editorial team is informed by
>> our goal to eliminate barriers to the generation and dissemination of
>> medical knowledge. Here are the latest updates!
>>
>> *We recently hosted a call for submissions contest for case reports, but
>> our authors didn’t submit alone. They had help from ChatGPT*, the
>> cutting-edge language model trained to assist with natural language
>> processing. With ChatGPT's assistance, authors have submitted detailed case
>> reports.
>>
>>
>>
>> Now, we're curious - do you think there's a place for ChatGPT in medical
>> publishing? Does this technology have the potential to revolutionize the
>> way we approach medical research and publishing or could this lead us down
>> a dangerous path?
>>
>>
>>
>> We would love to hear your thoughts on this exciting topic, so please
>> read, rate (using our *SIQ scoring system*
>> <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B9566-2Bqo7N8nBm4Im-2BnOwxeUWPVJZYbw1CCx6Vp7-2FDSXygE3GR_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2BztxlvY-2FhZICG0uLiqS5duhbNuJIwDMGW-2BVm0tlhfyvaj2mRG8orx4oYR9S9YRPRMV8YbJReKrgGZtVcEa97wRhAcOoqoz38DqPoVobFWLbttNBoTxpQWjU-2FEfjN-2Bb166CGtQssSmdSZXTRsfX9LQYH0RbwzlUmgyFemvfjQQpZbQx49H2QpULQ1TK8QnohY7vZrFbap2FxUibiKTtxWwjJA-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IH5CeTfb$>),
>> and comment on the case reports published so far. And don't forget to check
>> back often, as we expect over 100 more to be published this month!
>>
>>
>>
>> *The rating period will end on Tuesday, April 11th at 5PM ET and the
>> winning article will be chosen based on final SIQ ratings and announced on
>> Thursday, April 13th.* We appreciate your feedback and look forward to
>> discussing the future of medical publishing with you!
>>
>>
>>
>> *P.S. Were you an author of one of these case reports? Check to see if
>> your article qualifies for our article promotion
>> <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B955NXtZS9GQkunATlWFb99K77wwr00t8NGxJawdTMN888mn6lvUaDDOYLw2RHRj4wpQ-3D-3DYUxi_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2BzDLDzial-2FUZNlgY-2F75SvhLywaLySOQ-2BTzsf7CgoyZKjrAOkRMTkmpPlyTP1IlgmyD-2F-2FM-2BgE5p-2F-2B-2BgIhh6YqmRWt4uPahJIwx4oN6UJglr2WTC92xdVi2AfJUiR52KBx3kLJwOxKKJ-2B6KuwvTx7lmfHzHFM3whHC6khYtL2CDFO9uLVTaWjc2ZeFRayJLgdZJtonm1PtRa4Q4qnPrgSwTILw-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IKyXwIxC$>
>> service. Authors who purchase this service see a huge increase in article
>> reads and PDF downloads!*
>>
>> VIEW CHATGPT ARTICLES PUBLISHED SO FAR
>> <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B955NXtZS9GQkunATlWFb99K66tyaqfPa-2Fnqb2iFMlfjkfsCxdiejC6GxSEQjKZ2n4e-2FrLn-2FNIT8YReA33p7mnFPfVgPQP67ymvNwBTtbeZL6-2FpOWexlXvsxkzw0aZ8csrgXJUuJ-2Ft28QOoX0KJFZv76TsbNwA6zMS1oH5Qd4VbPLZ1MmCYzwteJXEuHjuXD-2FRvSHIX4hE-2B9IhyHEkDiE-2FxuC18Gp3wxYOgo9FRZxxxx97ztcZzGqG-2FQ0JGEdWHvz5P-2B-2BsHsq7ZDd6-2BARTm41e9-2BgyU0Xv7x8z2-2FYvulqgzIVEC6UXScQhCR9zFHkVejjuOiYzHhj-2BTpLrHTtmbKvP883YudwTt9SYcbdWIkf-2FqHuC40GkiZvyO0k5hQ6SLkOpdR-2BfqPFXyH4-2Fhf87ukKtXAPnADwc8XjgSldevNNIOZNYQzmCMGtqbwdLVczbQMWC1VmzOPmS4fs9j90XwqTadaWhQSmLxWdJXmt7ggTCX1U17qy7c0SJ0Vn324yUdiQ3GYzsUGS-2Bkd3kgPukiRtYpjlb8jEpSeOusmLCVCt8ly-2FjW2kt42jSskCZ2cdpJmpT8JgxnjAYaTGQ1jOUh4yISSAMI1hSXN3uF9jXY2uKR6XamkE81FcfkiYRlMkQHfd5vf6yPT5j2m3sN1JApgBWR7OjCrDV4Y1BhC1IHO5WySj30zPvut0a5okKB8E2W7yOoCB0ETE9T-2FZ9jccf9ZD-2F23oV-2BVLq1Yiow1eCe5YsIy6Z5q9fuIrdqeWfjN2r0Et1ngJAdxcgVQNpTxFkWYZvYE3ZuV7zlZD-2B2n-2BVM-2FAnDvb9izqPLLfB-2BFtEbv8ZVDRgXeK-2BWSiIN-2BXalVgxN9esG2U3NF9KTbOg68PDCsWWhOfA68ExR8RDRMJ6p5vac-2FgVlliiNfPQ5HdDxwchnkWsH36ASSok-2FDI4DTUeGaiEyczpCtaAQIhR7WxVwjwMzimxvEwoAOZrD7U3bsTMeaaNy2JZCLLtWtuEwiu-2FhMdaCs7wolWGtInX3gTi9z3ppW67llOBn07mFwl4bSMSblxKu8g-3DTSS3_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2BzEHLuImbqoabW27YTlAAw8QTCmySoimrNW3OaxcALSKdt0lIz70S3p8cu5S7dTlKP8FTGnaXJWuMQUDEGeuNHmUMSwKXDpZOb-2F0V07HoCfXG84CPbkxl1AnsknbbHDNMsRCAeeXYa69R9q3IbT7Rf-2FOYLryB5COd3pS1r9oQ-2FcxoTQKpNz7FF3xieqWv6hDyRFB-2B-2FPXj7lO4LqzhyIk9UMQ-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IHtSyLSN$>
>> ------------------------------
>>
>> *Do you have a Twitter account? If so, we invite you to follow our
>> Founder, President and Co-Editor-in-Chief, Dr. John Adler*, to read his
>> thoughts on the state of medical publishing, the US healthcare system, and
>> entrepreneurship.
>>
>> FOLLOW JOHN
>> <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B951qMZ043RtiIC74nTEaF3D1KiFeuGiHWt7EA4Z337J-2FzqqmJi6gFWMNrRpcceKH2MtrBsxF-2Bg1TJdLXn-2FVBwolebYcRp3-2Fwng9QqNt5PVczfIz6iGFcBQQE4dBmVB11hxzcc9cD8Q3qBkGZAPitDrZ23j5O0vBEYFirVmFXp-2B1R2rubDfkwO2qvB-2B0jpFwYp4ME7cRkIZ56M6r3N59hBThK6-2FHYyccSzM-2B-2BTxIjiRcf30qwIx8QV0-2FmFPH4wn-2BZ2vDLlKXbE2hAI3kyHPkPkNGgeGcYijjlUZL8cpgqghPfMgOUehtwThbLNo2lHEvaOVAaSTR-2Bt0ucNgSCwBKyqFI0-3D15Oz_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2Bz2UNV-2B-2F1MCh4rYOaOz-2FNRYxHa35oTJPctmBleDF-2Fe01JUQCPmpdOFuiBYr0p28v1wVsMbWeSoqNy6gIp9qVep0i3wXJh-2FAFZDHvkLbkQ-2FqGub6qbY-2B-2FselronuaT8TiqSqMfzWtC5-2FvNtiy-2B3bfVjY5kBXlmEdcTI8185b4jgUw4ELfgVy6Ds6y31eIvqrmkMjLeDeyv5N4IPOfJt55m6jQ-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IGjoAj-g$>
>> ------------------------------
>>
>> *Have you made your picture prognosis
>> <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B951EQ6NFuUc4yV11FbdQS1FTCMR8SZ1ApSa0DuVSl9vjd8Pkv_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2Bz1KvDkIbXtWxo1VW8lCHkG7A2I-2BnSh1tVADokXFMqt1duYdJorPLqfK8ZBb6iiRN6Wx6YhHc9j0PXZC4vuniG-2ByLWNxBNCr2c8YgfkKcoUUQj9URDuxrHjycAyNthE1Ojg7CsIIlRu27mDj-2FxHyYk2PijZTBWXfvUj9NMoOLjKq-2F-2Bd204RnllJG5GyDV31daZRA9zfd4-2B1pDXXOLSS2K73w-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IAquhjmo$> for
>> this week?*
>>
>> *You might also be interested in some of our most-read articles so far
>> this week:*
>>
>>    - Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective,
>>    Observational Study of 223,128 Subjects Using Propensity Score Matching
>>    <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B955NXtZS9GQkunATlWFb99K7aYHa7aA3uZCYlIpcW7OUMqOhPY6IVdDsEFOIW7rP7ZmdZAqXAriQtvFvVVAog4LiHt5jNzwdthq-2B4Hq2jAi-2BoF2ZwieGt4DsXXgzuaxGhBi1d65Z5wA-2BoXnLGgsXs0RN11N6q6CqYM50uHs9Lbi-2Bpy0kmOKT8y3iJMLGfVWy3hlOREZJubQSMKUrdcREJRliGc06Tq9KuUxF1qRzW1UArVam9_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2Bz4u-2BRXEsObP7V5zgGVFRoo8qdnMpQn7jp3rJQsliqxfYLML4J21q-2FYGiG3UykI2rbyRwN4dGxVkTkXpHnoG7xZe7AosSoi1ZUaAYD2SoahEfasiLt65YtZTdXbRrGeuEkwfLotngfooJ4iB27pqb35o-2Bkg-2FYnbcEIq39pNykvEqNsu-2B83JoJLbUC8JsrMnuuSvuqQezvXjoO159qkrvvovg-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IA6NfJNy$>
>>    - Chronic Venous Insufficiency and Lymphedema With Papillomatosis
>>    Cutis Lymphostatica, Hyperkeratosis, and Skin Ulcers: A Case Report
>>    <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B955NXtZS9GQkunATlWFb99K4Ph6-2BtVYYEaUJfJ31MhYX-2FNPYgua8TivNSMHunO4OBU5ga0E9FYgAXNjnoOtVRzLulsEMdOWEsspUSv90ufCYw0Wd9uxbf5jmKrJL2GHryIcgJKpd4RLnI-2FZRxKY3HvFmrIm0ncU1fX6VGlPi3pzCm7t-2FVcMOiLlSVxaXP1go7N86TwCi2NiDkh0broQvhB-2Fc-3Dhme5_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2BzneYAEg2wYYFj-2BELKrhQMXaXnrwbGEWKdpjfJyBuloyBe-2F7GNrayk4IA6QTibHIpTeEftdnW-2BEQyIRgJ65TXtwUMzlVeLp3jGHzigPyWOHdmC727sqsgdRgFuO4P03p9VDoRAUjnopnCabNbcN-2B0usxhYaBua-2BzCzQleW3VIVUr6CHHR8s22Nq9l-2FPGLFHc3t1VKTHh2zMOJB5EaZay842w-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IL3lIzWv$>
>>    - Artificial Hallucinations in ChatGPT: Implications in Scientific
>>    Writing
>>    <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B955NXtZS9GQkunATlWFb99K7tVcA3JmpLVSmMibWn-2BTFnc2FGbVYq3kOqH-2FJ5-2BUoo-2BTQqDbILwUdRCw6O2GACAo1jH3iMGuVTGE0FD51MRCqNbTt482JgECfFIFUX1rrQi2Tuxzi64Kz8U0OmiI4GFbw-3DRmDH_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2BzBodvqO5eZhxQJBJT02EaJdOmyNGVs-2FbEGZqGl11z4xBnMoFVybMlqXSirnNfXcgbqkkafOjdHFZrHgNXhhY-2F5JsyGR7CKYFXHMNCPOP4aEK1asjQ-2FVwEpniHZpuRbMabM1OhLtAtQsEjW6rEUlFXOXdJzdSFUhsUD30ehIOFcrW8pnRafeNI6ct7Eia-2ByFVRjlzY5y2yKSzdt0XkU9JlLg-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31ICVc5cuz$>
>>    - Astral Projection: A Strange Out-of-Body Experience in Dissociative
>>    Disorder
>>    <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B955NXtZS9GQkunATlWFb99K7UQHvll4z12QcAJSeO8-2F7uQGTUvuyW0Vnzj-2F0K441sQ50M4NoKbv610jGu4N6wJoDGCvQZwQNNcJILluuYaPnejeBcytqnbIYqLLsxMQj7fIewm9vhdCN8fQfFQOTtGRA-3D6k-S_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2BzqYIlgqene-2BRNStpg55wfqV0I2b-2FYQX9YEH79Kc8U7pkSX1gETuEZq1JkJUzeF1Or7jl9Ev3idYATg3qro-2F1pNDIJYGNrWAwplyNLRmam4H1mTXgzeOkZkKEIaGudBlMIWtw-2BRM2Nitz0mq-2FtcV-2BzcvgTM5pJLBRQjrAME0pGLGWVFIuPOSR4WaUFG-2BBXEltyV-2B6iC4LcSKj1YVKIabSy6Q-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IOiwqzGM$>
>>    - Adult Acquired Buried Penis: A Hidden Problem in Obese Men
>>    <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B955NXtZS9GQkunATlWFb99K7oSaVQzlsubjlxTQoC5kLTq9WscksBsN3wnaCnNShc30o7sOxtEWI97kvYW8w79WVS9QIolmR-2BfoA2RoEqnin17TyjTdz-2FjF2xebCNDdgLog-3D-3DVspf_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2BzO7EgpQTGdRxcgBt8-2FdXDOFcKAyLeOkPRUFITxd9jIrQcc3VR9ejoPhXvumWXHHEOh1jI8fjXnNPkAvNamMqr4f1tLgnAKPlF7-2BLKKF97jm-2B5H2-2F8mQWd5jpuu-2FcR5vuU7LGajvypwNnIQ7hTuqv8y1aZ-2B3cnT6GWsdHOgWXDEOURLLuZzM6OFS-2FlgAnqKD6ECMg2bii3r7tbHLzLBZjjXw-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IO2x4x6z$>
>>
>> ------------------------------
>>
>> Cureus is dedicated to eliminating the barriers many physicians and
>> researchers face when writing or accessing medical articles and we couldn't
>> do it without your support. We hope you will continue with us on this
>> journey towards a democratic and equitable medical publishing future.
>>
>> With gratitude,
>>
>> The Cureus Team
>> SUBMIT YOUR RESEARCH
>> <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B951EQ6NFuUc4yV11FbdQS1FRPtvyyxp55wLJanW8lq4mdGYxroSM-2BMgB9tJjufxSWZ-2FA5Ca-2Fr9J-2FvJo4xVMLfLe80vVWmzI3HBCSazfu05DBd4vYJv4Ms69E05BQxY946PkSIZVelkjYG7HGxr9Ls1r5ktB5mf1Iu96X3U-2B5GflQlf5Cp7Zde669M1jGveF-2FbUpKnzzOGdT9yA76BOihkWD3nnOrUd9fwUMrB-2FqeBem-2BpzONdIiaw-2BOSE7e2B-2FDIxHTtigEbQWI1EHcnI1WxHKrUAi6ridCtQZ0D2EMPn3D-2FQ7s8kzSouIkrNYEmBBoTDOmMzKgdla-2FgeiEaVxTiH8Twmip4nAYElU3uFBeZQ37WIPtHW_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2BzvtxSw241pwxQ-2BlK77SN8DF7Vqtczwd6HtzPToMRxH1wcdgMGkKJxrB-2Bk502Bv4iIAtWhTeVXOrC-2BgOeEDfMmHnw4jkJABnDzbFHlaC0B1oUjYA0SDt5Appka335uUsZdtzU8JBUc39WvRCrHCoOKtfS8bsZg2jo7I52wF01Pz6LG62m5JPTulnqWCmMBe91eC2G5253Le1R5h2UUAlAZ5g-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IN0lRWSH$>
>> Have any questions or feedback? Email us at support en cureus.com
>>
>>
>> <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B95w2rSzNng98V8sUPr-2FtrXHAsA0L-2BaZYRW3m8oiAYAGFqigN-2FLremuTKQqlPFRzyn4a7k91zU0MDM0dE6yyNoq3gA9cIA3WFpeD5kCQ8ea7M485E-2FoibwEU3snFzNnmPwmtwflT-2FFAy8Hu9NZaEzVFrUVkKS-2FyL6OOhGrfy4BjxMRFm7f_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2BzXfNnR9VdmLIZbfGnq8RhODX-2FpRKFJ55TkN66C2k98f2qmLHnLTHK-2F3KuvybJcLmmDzz2LQh-2FziHaLF02lVuY52gpH6Sq8pBG8dStoNlQSpUeJgpBe0LSewJvelllP0K24VcTm8Yw8FrxqOehiSuPeJljIwaz5LTw2N7-2Bv0Z5o93ViN6Sb0mbusNewl8mdf6YdSkjfFOmtWuROmXmsf9Q1w-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IEWM0z3p$>
>> <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B95w2rSzNng98V8sUPr-2FtrXHDTTNzq7NHI8xDIsSl9hYIq0T7DL0FO6kEL7RZAPPbcimXn9SUqgCnLZ5wllGipMskgKtfhqrlybve1qCiY0M0rnmbH24r2VFcFSEUlE-2FntHY0LCMGbP54l5x7PtJpFZa-2FEfASdKhpsa-2BtBXX2QruKMQdgu_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2Bz7z6qLSOa1VBkVHYhsQJDDJ5XQAk5ln8q5-2FKITMBFkFUhF-2FpyrxZO0qXYjkQCbAnuYmSy4-2BAioz1UzIbQPjBNLPJzY2S3xz-2BwB140wftZ9avmAzq1vU1Ic9aEuS-2BT-2F3h-2BCBkq7nsZi7WnxlTj0Bi7lIh43fCtXpDxQAa8XcIK0xVB-2FW6N34xLqqyDAmaa8Xd50TKCO2VUIwh14eM805GjyQ-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IMCqwJGS$>
>> This email was sent to pan4opik4u en gmail.com
>> Want to change how you receive these emails?
>> You can manage your preferences or unsubscribe here.
>> <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B959FRtTmQBYhsvApy9KQx6DG9SomcH2dXB8QMTQvLsEk5m5Kjg-2Fqw-2FS-2BLDi1gbjOUCApPh0UmznWfqZs5YAoEb69EyzOihxS7htzJ8q0sgkcG8KJU3t-2F22zZKD7LJVTBYng-2B0jWjL0QhDqQ-2FFKsffhMUpgJfUCe0dRp4JkDZHtqNhAo5Kd5J-2F0mZuwlVhkBnoJjFDvo4itCdFnmmvRL-2FTqj029xFq4hFRAJrFnSP6An-2BT565xo2aQ2c-2FehqRy4qZ4DubfEiQwJLHeFwGYPsTx1serTMfTLfJu6Y-2FoNujhNVmhSjlP-2FMFc8s2qZzXZkzglrzec0gYNf1IPvh6EMnlqn-2BMJD-2B230UtObWXZpA79xgnz3gNIku-2FEsJ6p4GZ-2B3vOeka37W0d2-2BYPJHcBFij5aN8CUmKkpMphJ-2BWm19kCp4PbquEYr8MJ7POc070dfVCrAPqCReAJwszORW77W-2F3ZdqrU-3D_KhY_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2BzOHXJ8CmKEusoffT0fjlPxvEB0Zsy8fCeVKMWKsYv5Xvdrxy0pCsJSpS5FNLp1kvSSIx-2Fq-2FC6sf-2Fmue3RHHRwGkLb9rQR8K6X50OBdWfNOET4bdyI1IC533SrTvtONSNY1pykfxg9Pgl-2FHX5VPFfPNx50Nvh4TXB-2FzicqrkVs3r0Ex513sz3QjIPINuYxRNmgFfiuuP8I8Y5-2BRcREEpqMlw-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IACVJIqR$>
>> Cureus Privacy Policy
>> <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B951EQ6NFuUc4yV11FbdQS1FT3q2c9RY52C9R8M-2BnwbiBik5wC5zH4d9NXXqDOrGQuW9la9Jst8TzL6KFPg5pyaJR5U3FjYbwO-2B4MdFAl-2FWXeg-2BhSgIMnHgXEX7f-2BTMWrwJ-2BjN-2BsjvsdTGkCYUYjHUsZV5YHsa0Il7AYjbSvUwDZaDUERV2BDADUdk32otSD-2BX2eaBaAapYZvb-2FpjRTKkh0d6ATuPDRmyMgHaOLnfK5cyQNUjdGpORGq5Ldqio4-2Fdx6uKC6ykhrsxsKwFFk8V9Lq8dGZZ8iT0zQpxFW7OjEBVRx63I8-2BoL-2FHhI83jJqZ-2B-2B3RNjdXf0CPPSN-2B4UJQRBMys-3DW7tM_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2Bz2MGIn0P-2BI2Xdb1e9bJJ5PKoTx6NERa6D8Ai9q4Hi-2B-2Fs4om-2FpEd-2Bm-2F4nHXR-2FsLCGxiG1-2Fmf7iR-2FZaXTFjrkM-2Bs3RMhlxUifAu4SbnYmh-2BMxTfw26VtSwvlDZo9G2H89ixDnwmKBo2sFw-2Bmz-2BzKRoMV2SYIIRBrO6gN7K-2BEtvf86xHoZn-2B-2BURboCNKqvYsRdtpwliLsnFYUwCjJEfY-2BAorqQ-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IGzNefP0$>
>>
>> <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B95yBZ8q7nIdN08wnkofcAvrYhfXY-2FqQV-2FTVH-2FKBvdLUTEAeh2TLj37DKGxAoP3gvXBXwV0IpxyDRqlvOyKXCzFjgdDdIt2ruKNkmfhm-2Fm4fDKZDn55VhgGRj-2B0EKBkY8WX-2FuK-2BhhNSclINsklxEdfVy6pdINBBA2xV3B6H1An21LgTZqyKHwszMVpbjynGnQ1TJXW1iTal9EbKsBLvcAo93pshBjkF4uo5w9kmkY221arfuRWNvMdFhX8QsXfVgiMZj4Xb3Nwxwf0NaUARSszxLcW0P3nKnku1pG6zcsPDR8t2BYidaOdkwXXLMEUBZoBpkPlIesz3Q4hYslbT-2B2dSzE-3DbUck_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2Bz0DqLW-2BXlAmw2mkIrZkVecnahqscp9rPo0gFBpbyYrvoiSvCgmtflAPwMGuKLRpdga8KB-2FpjmEOOLGfYMrBd1L2Ru0TyNbCCH9Q2XC1PRM0SkDcBSgjP3GUj6wORrkdBwznowWNUHGP7D1e49CwJyVLLsOqPbyZ-2F2QooO9BaW2wwLWulMpBHNOdpZZff3V0-2BALTtsJWNMilaPLgUtgLoGcA-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IO9yBMML$>
>> <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B955Dtifn-2FJKkLqmDRWrICgqVDal8MYrBqIpjY4svSTe78GkMoV4BrwR4EigVQqo47FScKMBDjWA190VTgTOyShswx9d7rSKM9hynmq-2FsvHCEK2RP-2FbWhgM75AuPGGuK6VjGOmlXlLKGTMwDMpWxShZANGu-2F1xGoPZOTfi5oMeSwAcW8y8UcAR-2F35XiI5-2B24m5B-2FqQ4hVYAZi77K-2FHM21NxYEftSRCcgSXEnIBgAD5Yw0KMbI28LnRG3v7zGFLDKlazYN33AcGEOLGbYZzOyEptrMcImJ5gcKLbpgiA41FDCcBQjEUuBO4TV9IM9EADGi-2FpGCVaoLW9kYd3XhgzkYXFyE-3DuZH-_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2Bzn1TQw33RhEzR-2F8JgHOc3-2Bbp0QqCm-2F-2FQTdSg-2BXeVadti0hRF-2F9-2BY92nu0TzTdPhIBEIXYYNoDLJuoEByWFkrKRPK8Ea-2BrsHLfTCdgmjegNgqZOn7GTGbivXimvLYE0hmw3lnimvvxOJh2RqF3cDxzJUCMhkQUmbLJAT66lwH-2BRAUrGS23Wu3dtCi-2F33OQXnZXnmUr7yiNzrg-2BTUdlRQgWQw-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31ID4bXxa7$>
>> <https://urldefense.com/v3/__https://u3957313.ct.sendgrid.net/ls/click?upn=N1nBeuHZjGq5H6A10V-2B9523kaF0BnCZcggx5OMGbX9dijC3vv5Isq1aNrzqtxpoPMnBQ1dDYFO8zeX-2FWAcj0zwilAd7XHOCu-2BLtctKCFgbOXew077s7xNuUV1eSQKfqpc9DF5QjFabI1-2BTYy-2Fma3Hg5iuZQ0OScepa4QkbfthEmKBjgnVO1aiDA-2BqUFoO-2BZI82AxLQw2fYZ23ajDyVSPFrvzfoL3mrV1JGClc3115oczK19z17b9-2BE8ghDtrSi6YdfJIcypU8kGeQ-2FCbvI1IcQT1VTPOYjXHd8ektsgIaUHOUhwzgVDPVsSDhWZ354ON4jV4w48RQLob3ZfdY0-2BOmV3-2FOt3xGXGM9w80v3sonNLoyz7MItwZLfCU3gwwBwXhYb7e_YZSw55rClhWpep-2BlqNiXNpBhZBIGJmmnQF1mTaHCWTSqfm6uMVU3OIphpL7kAJ-2BzaA0r8bSo7poOSIUCk9dHQA92iJWa5Uk03Ns7ClHQDG0jS2w3HcjWojVzARx9UsjXunZnFPM30etb-2Ftqkl5FEj1zw3bKptLssEzQ-2FypT0v07eWq8r0lMNGrE0lrZvkmzNBOcOLo-2Biakay5WuXfMeJ4Xk-2FAnN5KVaJY5yQzjBHu6gnYmYY3wDNWEUMpVL0fsJSQroVS-2F6Y6qnFjHZyg3S0GQ-3D-3D__;!!D9dNQwwGXtA!WpLdqI4jbcagq8L4v0JpSLg79Pb8LOp6pOEFSOB21kUFvL21fZO99gtBsvisbf7F12anCP7KhMv9hI5VuV31IBYcI5zM$>
>> © 2023 Cureus, Inc., All rights reserved.
>> Our mailing address: Cureus, Inc. 239 Brannan Street, San Francisco, CA
>> 94107
>> _______________________________________________
>> Fis mailing list
>> Fis en listas.unizar.es
>> http://listas.unizar.es/cgi-bin/mailman/listinfo/fis
>>
>
>
> <https://urldefense.com/v3/__https://www.avast.com/sig-email?utm_medium=email&utm_source=link&utm_campaign=sig-email&utm_content=webmail__;!!D9dNQwwGXtA!RMyObP_qYnWgrYsmsstVgMRfYwaNSyiJMlFQFQYY2hXhSfJ68SmO88Q6z0W9-c0jpfIS3tXpHDWvOQ3PMdw$> Няма
> вирусиhttps://urldefense.com/v3/__http://www.avast.com__;!!D9dNQwwGXtA!S_6e37iI51KvXV9V28XNNjRCVNs6KEFPzZZgIikDzBH_0slTTcL6B4CH80lVvsmgJpp16hyhGZSV-UJKd9VmDLOpAWg$ 
> <https://urldefense.com/v3/__https://www.avast.com/sig-email?utm_medium=email&utm_source=link&utm_campaign=sig-email&utm_content=webmail__;!!D9dNQwwGXtA!RMyObP_qYnWgrYsmsstVgMRfYwaNSyiJMlFQFQYY2hXhSfJ68SmO88Q6z0W9-c0jpfIS3tXpHDWvOQ3PMdw$>
> <#m_5865916017332080069_DAB4FAD8-2DD7-40BB-A1B8-4E2AA1F9FDF2>
> _______________________________________________
> Fis mailing list
> Fis en listas.unizar.es
> http://listas.unizar.es/cgi-bin/mailman/listinfo/fis
> ----------
> INFORMACIÓN SOBRE PROTECCIÓN DE DATOS DE CARÁCTER PERSONAL
>
> Ud. recibe este correo por pertenecer a una lista de correo gestionada por
> la Universidad de Zaragoza.
> Puede encontrar toda la información sobre como tratamos sus datos en el
> siguiente enlace:
> https://sicuz.unizar.es/informacion-sobre-proteccion-de-datos-de-caracter-personal-en-listas
> Recuerde que si está suscrito a una lista voluntaria Ud. puede darse de
> baja desde la propia aplicación en el momento en que lo desee.
> http://listas.unizar.es
> ----------
>
------------ pr�xima parte ------------
Se ha borrado un adjunto en formato HTML...
URL: <http://listas.unizar.es/pipermail/fis/attachments/20230310/8ab07d2a/attachment-0001.html>

More information about the Fis mailing list